Physician profile
Isaac L Mitchell
NPI 1760592695
$53,000.00
in general payments reported to CMS, 2019-2025
7 companies · $426 in 2025
The $426 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $16K · 2021: $1,561 · 2022: $11K · 2023: $3,257 · 2024: $9,129 · 2025: $426.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Travel and Lodging: $1,343 · Food and Beverage: $890.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,578.82 |
| Travel and Lodging | $1,343.36 |
| Food and Beverage | $889.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lima USA, INC. | $37,747.88 | 2019-2023 | Smr Shoulder |
| Medacta USA, INC. | $8,109.87 | 2019-2024 | Reverse Shoulder |
| Encore Medical, LP | $2,859.74 | 2024 | Djo Surgical |
| Limacorporate S.P.A. | $2,233.42 | 2019-2024 | Smr Shoulder System, Smr Shoulder |
| Arthrex, INC. | $1,536.12 | 2019-2025 | |
| Cgg Medical INC | $450.94 | 2022-2025 | |
| Depuy Synthes Sales INC. | $62.03 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Isaac Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.